中文

红日药业 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-29
ItemAmountY/Y
Revenue¥1.13B-18.9%
Gross profit¥0.65B
Operating income¥0.08B
Net income¥0.07B+10.9%
Gross margin57.4%Net margin 6.1%
Revenue Q/Q+42.6%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.48B42.6%
R&D¥0.05B4.0%
SG&A¥0.49B43.1%
Tax & other¥0.02B1.4%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

ST华谊阳普医疗宝通科技金龙机电钢研高纳中科电气超图软件新宙邦上海凯宝九洲集团回天新材朗科科技

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies